Factors affecting parametrial involvement in cervical cancer patients with tumor size ≤4 cm and selection of low-risk patient group
- PMID: 33506671
- PMCID: PMC7944230
- DOI: 10.4274/jtgga.galenos.2020.2020.0153
Factors affecting parametrial involvement in cervical cancer patients with tumor size ≤4 cm and selection of low-risk patient group
Abstract
Objective: The primary aim of this study was to evaluate the factors affecting parametrial involvement in cervical cancer patients with tumor size ≤4 cm and selection of the low-risk patient group based on long-term oncologic outcomes.
Material and methods: Cervical cancer patients operated in the gynecologic oncology division between 2007 and 2013 were retrospectively evaluated. One-hundred and sixty-eight patients with tumor size ≤4 cm were identified. Of these, 159 (86.8%) underwent radical hysterectomy plus pelvic-para-aortic lymphadenectomy and nine (13.2%) underwent fertility-sparing surgery [radical trachelectomy (n=7); large conization (n=2)]. Factors affecting parametrial invasion, including lymphovascular space invasion (LVSI), deep stromal invasion (DSI), lymph node metastases, and tumor size, were evaluated. Statistical analyses were performed using SPSS 23.0 (IBM Corp., Armonk, NY, USA).
Results: Median age was 49.5 years and median tumor size was 2.5 cm (0.45-4 cm). In both univariate and multivariate analyses, the risk of parametrial involvement was increased with LVSI with a hazard ratio (HR) of 3.45 [95% confidence interval (CI): 1.1-10.8] and DSI with a HR of 4.1 (95% CI: 1.18-14.8), while tumor size of ≤2 cm was only significant in univariate analyses. Furthermore, 26 early-stage patients were identified with low-risk factors and they had no parametrial involvement, lymph node metastases, recurrence, or death from disease over 77 months.
Conclusion: Parametrial involvement in low-risk cervical cancer is very rare and less radical procedures may be safe in these patients.
Keywords: parametrial invasion; Low-risk cervical cancer; less radical surgery.
Conflict of interest statement
Similar articles
-
Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.J Gynecol Obstet Hum Reprod. 2021 Oct;50(8):102145. doi: 10.1016/j.jogoh.2021.102145. Epub 2021 Apr 10. J Gynecol Obstet Hum Reprod. 2021. PMID: 33848645
-
Clinical and pathological characteristics related to parametrial involvement in clinical early-stage cervical cancer.Ginekol Pol. 2016;87(6):417-21. doi: 10.5603/GP.2016.0018. Ginekol Pol. 2016. PMID: 27418217
-
Parametrial involvement in women with low-risk, early-stage cervical cancer.Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12583. Epub 2016 Oct 5. Eur J Cancer Care (Engl). 2017. PMID: 27704641
-
Minimizing Fertility-sparing Treatment for Low Volume Early Stage Cervical Cancer; Is Less the (R)Evolution?Anticancer Res. 2020 Jul;40(7):3651-3658. doi: 10.21873/anticanres.14354. Anticancer Res. 2020. PMID: 32620604 Review.
-
Cervical cancer: combined modality therapy.Cancer J. 2001 Jul-Aug;7 Suppl 1:S47-50. Cancer J. 2001. PMID: 11504285 Review.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Plante M, Gregoire J, Renaud MC, Roy M. The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol. 2011;121:290–7. - PubMed
-
- Creasman WT, Zaino RJ, Major FJ, DiSaia PJ, Hatch KD, Homesley HD. Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A gynecologic oncology group study. Am J Obstet Gynecol. 1998;178(1 Pt 1):62–5. - PubMed
-
- Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S43–103. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources